These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16106238)

  • 41. Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice.
    Zhao L; Sun L; Wang H; Ma H; Liu G; Zhao Y
    J Leukoc Biol; 2007 Jun; 81(6):1386-94. PubMed ID: 17369496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
    Park HB; Paik DJ; Jang E; Hong S; Youn J
    Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.
    Dieckmann D; Plöttner H; Dotterweich S; Schuler G
    Immunology; 2005 Jul; 115(3):305-14. PubMed ID: 15946248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
    Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
    Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Janus face of CD4+CD25+ regulatory T cells in cancer and autoimmunity.
    Danese S; Rutella S
    Curr Med Chem; 2007; 14(6):649-66. PubMed ID: 17346153
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.
    Sakaguchi S
    Annu Rev Immunol; 2004; 22():531-62. PubMed ID: 15032588
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis.
    Morgan ME; Witteveen HJ; Sutmuller RP; de Vries RR; Toes RE
    Hum Immunol; 2004 Nov; 65(11):1319-27. PubMed ID: 15556682
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Flt3 ligand expands CD4+ FoxP3+ regulatory T cells in human subjects.
    Klein O; Ebert LM; Zanker D; Woods K; Tan BS; Fucikova J; Behren A; Davis ID; Maraskovsky E; Chen W; Cebon J
    Eur J Immunol; 2013 Feb; 43(2):533-9. PubMed ID: 23124877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
    Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
    J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Naturally arising CD25+CD4+ regulatory T cells in tumor immunity.
    Nomura T; Sakaguchi S
    Curr Top Microbiol Immunol; 2005; 293():287-302. PubMed ID: 15981485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders.
    Kondĕlková K; Vokurková D; Krejsek J; Borská L; Fiala Z; Ctirad A
    Acta Medica (Hradec Kralove); 2010; 53(2):73-7. PubMed ID: 20672742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Migration rules: functional properties of naive and effector/memory-like regulatory T cell subsets.
    Huehn J; Siegmund K; Hamann A
    Curr Top Microbiol Immunol; 2005; 293():89-114. PubMed ID: 15981477
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of regulatory T cells in controlling immunologic self-tolerance.
    Takahashi T; Sakaguchi S
    Int Rev Cytol; 2003; 225():1-32. PubMed ID: 12696589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled autoimmunity in CNS maintenance and repair: naturally occurring CD4+CD25+ regulatory T-Cells at the crossroads of health and disease.
    Kipnis J; Schwartz M
    Neuromolecular Med; 2005; 7(3):197-206. PubMed ID: 16247180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New Treg cell-based therapies of autoimmune diseases: towards antigen-specific immune suppression.
    Mikami N; Kawakami R; Sakaguchi S
    Curr Opin Immunol; 2020 Dec; 67():36-41. PubMed ID: 32827951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reprogramming the immune system using antibodies.
    Graca L; Waldmann H
    Methods Mol Biol; 2006; 333():247-68. PubMed ID: 16790855
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thymosin alpha1: the regulator of regulators?
    Pierluigi B; D'Angelo C; Fallarino F; Moretti S; Zelante T; Bozza S; De Luca A; Bistoni F; Garaci E; Romani L
    Ann N Y Acad Sci; 2010 Apr; 1194():1-5. PubMed ID: 20536444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulatory T cells in human disease and their potential for therapeutic manipulation.
    Taams LS; Palmer DB; Akbar AN; Robinson DS; Brown Z; Hawrylowicz CM
    Immunology; 2006 May; 118(1):1-9. PubMed ID: 16630018
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Central CD4
    Klein L; Robey EA; Hsieh CS
    Nat Rev Immunol; 2019 Jan; 19(1):7-18. PubMed ID: 30420705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.